SynthesisMedicine2018

The use of a novel non-steroidal mineralocorticoid receptor antagonist finerenone for the treatment of chronic heart failure: A systematic review and meta-analysis.

Hui Pei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.